Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSENTAN vs RELUGOLIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOSENTAN vs RELUGOLIX: Safety Overview

Metric BOSENTAN RELUGOLIX
Total FAERS Reports 19,581 20,660
Deaths Reported 4,346 958
Death Rate 22.2% 4.6%
Hospitalizations 8,862 1,699
Average Patient Age 52.5 yrs 72.4 yrs
% Female Patients 73.2% 1.4%
FDA Approval Date Apr 26, 2019 Dec 18, 2020
Manufacturer Actelion Pharmaceuticals US, Inc. Sumitomo Pharma America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription